C E Behrendt

Summary

Publications

  1. ncbi Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy
    Carolyn E Behrendt
    Clinical Safety and Epidemiology, Pfizer Global Reserach and Development La Jolla, San Diego, CA, USA
    Thromb Haemost 90:734-7. 2003
  2. ncbi Re: "hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study"
    Carolyn E Behrendt
    Am J Epidemiol 167:751; author reply 751-2. 2008
  3. ncbi Acute respiratory failure in the United States: incidence and 31-day survival
    C E Behrendt
    Children s Hospital, San Diego, CA, USA
    Chest 118:1100-5. 2000
  4. ncbi Visual acuity and its decrease in classic neovascular age-related macular degeneration
    Carolyn Behrendt
    Epidemiology, Pfizer Global Research and Development, La Jolla, California, USA
    Ophthalmic Epidemiol 11:359-67. 2004
  5. ncbi Cerebral ischemic events in patients with advanced lung or prostate cancer
    Carolyn E Behrendt
    Epidemiology, Safety and Risk Management, Pfizer Global Research and Development, La Jolla, CA, USA
    Neuroepidemiology 24:230-6. 2005
  6. ncbi Hyperglycemia among persons with hepatitis C: not the classical diabetic phenotype
    Carolyn E Behrendt
    Epidemiology, Safety and Risk Management, Pfizer Global Research and Development, La Jolla, CA, USA
    Diabetes Res Clin Pract 71:68-74. 2006
  7. ncbi Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles
    Carolyn E Behrendt
    Epidemiology, Pfizer Global Research and Development
    Chest 128:1239-44. 2005
  8. ncbi Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis
    J S Bradley
    Division of Infectious Diseases, Children s Hospital, San Diego, CA, USA
    Pediatr Infect Dis J 20:19-24. 2001
  9. ncbi Treatment-subgroup interaction: an example from a published, phase II clinical trial
    Carolyn E Behrendt
    Department of Biostatistics, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA
    Contemp Clin Trials 30:279-81. 2009

Collaborators

  • E R Wald
  • J S Bradley
  • J P Iaconis
  • A C Arrieta
  • C J Harrison
  • A M Loeffler

Detail Information

Publications9

  1. ncbi Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy
    Carolyn E Behrendt
    Clinical Safety and Epidemiology, Pfizer Global Reserach and Development La Jolla, San Diego, CA, USA
    Thromb Haemost 90:734-7. 2003
    ..We can conclude that combined treatment with 15 mg prinomastat plus chemotherapy approximately doubles the hazard of VTE among patients with advanced NSCLC...
  2. ncbi Re: "hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study"
    Carolyn E Behrendt
    Am J Epidemiol 167:751; author reply 751-2. 2008
  3. ncbi Acute respiratory failure in the United States: incidence and 31-day survival
    C E Behrendt
    Children s Hospital, San Diego, CA, USA
    Chest 118:1100-5. 2000
    ..Design and setting: Retrospective cohort drawn from the Nationwide Inpatient Sample of 6. 4 million discharges from 904 representative nonfederal hospitals during 1994...
  4. ncbi Visual acuity and its decrease in classic neovascular age-related macular degeneration
    Carolyn Behrendt
    Epidemiology, Pfizer Global Research and Development, La Jolla, California, USA
    Ophthalmic Epidemiol 11:359-67. 2004
    ..To identify factors affecting visual acuity and its decrease in eyes with subfoveal choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD)...
  5. ncbi Cerebral ischemic events in patients with advanced lung or prostate cancer
    Carolyn E Behrendt
    Epidemiology, Safety and Risk Management, Pfizer Global Research and Development, La Jolla, CA, USA
    Neuroepidemiology 24:230-6. 2005
    ..6, 95% CI 2.0-10.5, adjusted for conventional stroke risks). Further studies are needed to verify this preliminary finding and determine its generalizability to advanced tumors other than lung or prostate cancer...
  6. ncbi Hyperglycemia among persons with hepatitis C: not the classical diabetic phenotype
    Carolyn E Behrendt
    Epidemiology, Safety and Risk Management, Pfizer Global Research and Development, La Jolla, CA, USA
    Diabetes Res Clin Pract 71:68-74. 2006
    ....
  7. ncbi Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles
    Carolyn E Behrendt
    Epidemiology, Pfizer Global Research and Development
    Chest 128:1239-44. 2005
    ..To investigate the risk of COPD among nonsmokers...
  8. ncbi Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis
    J S Bradley
    Division of Infectious Diseases, Children s Hospital, San Diego, CA, USA
    Pediatr Infect Dis J 20:19-24. 2001
    ..This prospective study investigates the outcomes when children who meet specified criteria are discharged to complete parenteral antibiotic therapy at home...
  9. ncbi Treatment-subgroup interaction: an example from a published, phase II clinical trial
    Carolyn E Behrendt
    Department of Biostatistics, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA
    Contemp Clin Trials 30:279-81. 2009
    ..This real-world example of treatment-subgroup interaction highlights the need to employ phase II designs that consider between-patient heterogeneity and the possibility that efficacy differs by subgroup...